Oloduo

As the world’s first fixed dose combination of rosuvastatin and olmesartan, Oloduo provides ideal treatment for concomitant hypertension and dyslipidemia. Its patented double-layered tablet formulation prevents drug-to-drug interaction.

Composition

• Rosuvastatin & Olmesartan.

Indication

• Concomitant Hypertension, Dyslipidemia.

Specification

• Doubled layered tablet [olme/rosu] 40mg/20mg, 20mg/10mg,